New antiepileptic drugs that are second generation to existing antiepileptic drugs

This publication has 51 references indexed in Scilit:

• Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
  Epilepsy Research, 2004
• The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
  Proceedings of the National Academy of Sciences, 2004
• New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
  Current Opinion in Neurology, 2003
• New Antiepileptic Drugs Currently in Clinical Trials: Is There a Strategy in Their Development?
  Therapeutic Drug Monitoring, 2002
• Pros and cons for the development of new antiepileptic drugs.
  CNS Drugs, 2002
• The New Antiepileptic Drugs Pharmacological and Clinical Aspects
  Current Pharmaceutical Design, 2000
• Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects
  Clinical Pharmacology & Therapeutics, 1999
• Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
  Epilepsy Research, 1999
• The impact of new antiepileptic drugs on the prognosis of epilepsy
  Neurology, 1996
• Synthesis andin VitroReactivity of 3-Carbamoyl-2-phenylpropionaldehyde and 2-Phenylpropenal: Putative Reactive Metabolites of Felbamate
  Chemical Research in Toxicology, 1996